 Product Search |
|
| Input Product Name Or Cas No. |
| Category |
| Products |
 1,1-Dimethylethyl N-[1-[6-chloro-3-(3,5- |
| tert-butyl (1-(3-chloro-6-(3-cyano-2-(me |
| 1,1,2,2,3,3,4,4-Octafluoro-1,4-butanedis |
| 1,1-Difluoromethanedisulfonyl difluoride |
| 1,1,2,2,3,3,4,4,5,5-Decafluoro-1,5-penta |
| 1-Chloro-4-[2-(chloromethyl)-5,5-dimethy |
| 1-Chloro-4-[2-(chloromethyl)-4,4-dimethy |
| 3-Fluoro-5-nitro-4-[[(tetrahydro-2H-pyra |
| 3-Fluoro-5-nitro-4-[[[1-(3-oxetanyl)-4-p |
| 3-Fluoro-5-nitro-4-[(4-piperidinylmethyl |
| 1,1-Dimethylethyl 4-[[[4-(aminosulfonyl) |
| 4-Fluoro-2-(1H-pyrrolo[2,3-b]pyridin-5-y |
| 7,7-Dimethyl-8-methylene-1,4-dioxaspiro[ |
| 7,7,8,8-Tetramethyl-1,4-dioxaspiro[4.5]d |
| 1-Chloro-4-[2-(chloromethyl)-4,4,5,5-tet |
| N-[4-(2-Methoxyacetyl)-2-nitrophenyl]ace |
| Ethanone, 1-(4-aminophenyl)-2-methoxy- |
| N-[6-Chloro-5-[2-(dimethylamino)ethenyl] |
| tri-p-tolylsulfonium 2-((adamantane-1-ca |
| Benzene, 1-[3,3-dimethyl-1-[(trimethylsi |
| (4-methoxyphenyl)diphenylsulfonium 2,4,6 |
| bis(4-(tert-butyl)phenyl)iodonium 2-(ada |
| 4-(4-(tert-butyl)phenyl)-1,4-oxathian-4- |
| (4-(cyclohexylsulfonyl)phenyl)diphenylsu |
| mono(triphenylsulfonium) mono((2,2,3,3,4 |
| mono(tris(3-methoxyphenyl)sulfonium) mon |
| 4-(4-(tert-butyl)phenyl)-1,4-oxathian-4- |
| 1-(4-Methoxyphenyl)-3,3-dimethyl-1-butan |
| 1-(9,10-Dihydro-9,10-dioxo-2-anthracenyl |
| 2-Propanol, 1,1′-[9H-fluoren-9-ylidene |
| 1,1′-[9H-Fluoren-9-ylidenebis[6,2-naph |
| 1,1′-[9H-Fluoren-9-ylidenebis(6,2-naph |
| 3′,6′-Bis(2-oxiranylmethoxy)spiro[9H |
| 2,2′-[9H-Fluoren-9-ylidenebis(6,2-naph |
| 1,1′-[9H-Fluoren-9-ylidenebis([1,1′- |
| Ethanol, 2,2′-[spiro[9H-fluorene-9,9 |
| Oxirane, 2,2′-[9H-fluoren-9-ylidenebis |
| 3,3,3-Trifluoropropyl 2,2-difluoro-3-[(2 |
| (2-bromoadamantan-1-yl)methanol |
| 3-(4-Formylphenoxy)benzaldehyde |
| 2-(2,5-dioxopyrrolidin-1-yl)ethyl acryla |
| 3-Ethyl-3-[[(2-methyl-2-oxiranyl)methoxy |
| 2-methyladamantane-1-carboxylic acid |
| (3-ethyl-1,5-dioxaspiro[5.5]undecan-3-yl |
| (5-Ethyl-2-methyl-2-phenyl-1,3-dioxan-5- |
| 2-((((2-isopropyladamantan-2-yl)oxy)carb |
| 2-((((2-ethyladamantan-2-yl)oxy)carbonyl |
| 2-((((2-methyladamantan-2-yl)oxy)carbony |
| 2-(Hexahydro-2-oxo-3,5-methano-2H-cyclop |
| 1,1-Dimethylethyl 4-[4-fluoro-3-(methoxy |
|
| Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| RovathinS26705 | Bifendate | 73536-69-3 | 95% |
| RovathinS26706 | 1-(4-(4-bromophenoxy)phenyl)ethanone | 54916-27-7 | 95% |
| RovathinS26707 | N-Boc-DL-2-phenylglycinol | 67341-01-9 | 95% |
| RovathinS26708 | Dapoxetine hydrochloride | 129938-20-1 | 95% |
| RovathinS26709 | 1H-Pyrrole-3-carboxylic acid, 2,5-dihydro-4-hydroxy-5-oxo-1-phenyl-, ethyl ester | 57056-57-2 | 95% |
| RovathinS26710 | 3-Ethyl-2-benzimidazolinone | 10045-45-1 | 95% |
| RovathinS26711 | 6,7-Dinitro-2,3-dihydroxyquinoxaline | 2379-57-9 | 95% |
| RovathinS26712 | [1,1'-Biphenyl]-4-carboxamide, 2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[3-(4-methyl-1-piperazinyl)-4-[(methylsulfonyl)oxy]phenyl]- | 256227-78-8 | 95% |
| RovathinS26713 | [1,1'-Biphenyl]-4-carboxamide, N-[4-hydroxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)- | 256227-77-7 | 95% |
| RovathinS26714 | [1,1'-Biphenyl]-4-carboxamide, N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)- | 148672-15-5 | 95% |
| RovathinS26715 | Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)-, dihydrochloride | 67469-75-4 | 95% |
| RovathinS26716 | Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)- | 67469-57-2 | 95% |
| RovathinS26717 | 1-(Aminomethyl)cyclohexaneacetic acid | 60142-96-3 | 95% |
| RovathinS26718 | N-[3-[[2-(4-Aminofurazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[[2-(4-morpholinyl)ethyl]oxy]benzamide | 850664-21-0 | 95% |
| RovathinS26719 | [1,1'-Biphenyl]-4,4'-dicarboxamide, N4'-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2-methyl- | 691846-63-6 | 95% |
| RovathinS26720 | 2-Thiophenecarboxamide, 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]- | 660868-91-7 | 95% |
| RovathinS26721 | 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide hydrochloride | 635702-64-6 | 95% |
| RovathinS26722 | 3-Phenylsulfonyl-8-(piperazin-1-yl)quinoline | 607742-69-8 | 95% |
| RovathinS26723 | 2H-Pyrrolo[3,2-b]pyridin-2-one, 1,3-dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]- | 504433-23-2 | 95% |
| RovathinS26724 | 2-[3-[3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]propoxy]phenyl]acetic acid hydrochloride | 405911-17-3 | 95% |
| RovathinS26725 | Benzeneacetic acid, 3-[3-[[[2-chloro-3-(trifluoromethyl)phenyl]methyl](2,2-diphenylethyl)amino]propoxy]- | 405911-09-3 | 95% |
| RovathinS26726 | Propanoic acid, 2-[[4-[2-[[(cyclohexylamino)carbonyl](4-cyclohexylbutyl)amino]ethyl]phenyl]thio]-2-methyl- | 265129-71-3 | 95% |
| RovathinS26727 | [1,1'-Biphenyl]-4-carboxamide, 4'-(aminoiminomethyl)-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl- | 256227-71-1 | 95% |
| RovathinS26728 | Methanesulfonic acid, 1,1,1-trifluoro-, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepin-2-yl ester | 234113-94-1 | 95% |
| RovathinS26729 | [1,1'-Biphenyl]-4-carboxamide, 4'-acetyl-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]- | 162408-66-4 | 95% |
| RovathinS26730 | [1,1'-Biphenyl]-4-carboxamide, N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)- | 148672-13-3 | 95% |
| RovathinS26731 | 1-(4-Aminophenyl)-3-methylcarbamoyl-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine | 143692-18-6 | 95% |
| RovathinS26732 | Morpholine, 4-[[2-[2-(acetyloxy)ethyl]-2,3-dihydro-4-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]quinolin-8-yl]sulfonyl]- | 745046-84-8 | 95% |
| RovathinS26733 | Pyridine, 4-(1H-imidazol-4-ylmethyl)-, dihydrobromide | 699020-93-4 | 95% |
| RovathinS26734 | Piperidine, 4-(1H-imidazol-4-ylmethyl)-, dihydrobromide | 164391-47-3 | 95% |
|
|
|
|
